Inhibrx Biosciences Inc's total assets for Q1 2026 were $183.97M, an increase of 25.59% from the previous quarter. INBX total liabilities were $205.00M for the fiscal quarter, a 48.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.